Supernus Pharmaceuticals, Inc. (SUPN)
48.37
-1.09
(-2.20%)
USD |
NASDAQ |
Apr 28, 14:37
Supernus Pharmaceuticals EPS Diluted (Quarterly) : -0.0716 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Corcept Therapeutics, Inc. | 0.1994 |
| BridgeBio Pharma, Inc. | -0.9964 |
| Cytokinetics, Inc. | -1.495 |
| Oncotelic Therapeutics, Inc. | 0.5656 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.105M |
| Revenue (Quarterly) | 211.57M |
| Total Expenses (Quarterly) | 215.68M |
| Enterprise Value | 2.580B |
| Gross Profit Margin (Quarterly) | 77.30% |
| Profit Margin (Quarterly) | -1.94% |
| Earnings Yield | -1.41% |
| Normalized Earnings Yield | -0.9167 |